Getting clinical evidence into practice for the management and prevention of stroke

ISRCTN	ISRCTN09442466
DOI	https://doi.org/10.1186/ISRCTN09442466
Secondary identifying numbers	RCHA225

Submission date: 23/01/2004
Registration date: 23/01/2004
Last edited: 18/01/2010

Recruitment status: No longer recruiting
Overall study status: Completed
Condition category: Circulatory System

Prospectively registered

Protocol

Statistical analysis plan

Results

Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr John Wright
Scientific

Bradford Hospitals NHS Trust
Bradford Royal Infirmary
Duckworth Lane
Bradford
BD9 6RJ
United Kingdom

Phone	+44 (0)1274 364 279

Study information

Study design	Randomised controlled trial
Primary study design	Interventional
Secondary study design	Randomised controlled trial
Study setting(s)	Other
Study type	Prevention
Scientific title
Study objectives	Evaluation of the development and implementation of evidence-based guidelines for two key important clinical areas (TIAs and AF) in primary care. The implementation of evidence-based guidelines on the treatment and prevention of TIAs and AF in Bradford will produce direct patient benefit. The guidelines will lead to improved quality and consistency of clinical care as well as appropriate and efficient use of local health services. The results of the evaluation will be used to inform purchasers and providers of health care about effective and practical strategies for implementing effective health care to prevent stroke. The study will provide the NHS and PCTs with a practical model for implementation as well as adding to the knowledge base of the Cochrane Collaboration.
Ethics approval(s)	Not provided at time of registration
Health condition(s) or problem(s) studied	Cerebrovascular disease; Transient Ischaemic Attack (TIA)
Intervention	Not provided at time of registration
Intervention type	Other
Primary outcome measure	Number and appropriateness of referrals to TIA and anticoagulant clinics. These will be measured from patient information recorded at the referral clinics.
Secondary outcome measures	Changes in risk factors (smoking status, BMI, blood pressure) and interventions (proportion of patients taking antiplatelet agents, anticoagulants, anti-hypertensives and statins) recorded in primary care records. These will be estimated from a review of general practice records 6 months after referral.
Overall study start date	09/01/2001
Completion date	03/01/2004

Eligibility

Participant type(s)	Patient
Age group	Not Specified
Sex	Not Specified
Target number of participants	Not provided at time of registration
Key inclusion criteria	Patients from 3 primary care trusts
Key exclusion criteria	Does not match inclusion criteria
Date of first enrolment	09/01/2001
Date of final enrolment	03/01/2004

Locations

Countries of recruitment

England
United Kingdom

Study participating centre

Bradford Hospitals NHS Trust

Bradford
BD9 6RJ
United Kingdom

Sponsor information

NHS R&D Regional Programme Register - Department of Health (UK)
Government

The Department of Health
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Phone	+44 (0)20 7307 2622
Email	dhmail@doh.gsi.org.uk
Website	http://www.doh.gov.uk

Funders

Funder type

Government

NHS Executive Northern and Yorkshire (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to share	No
IPD sharing plan summary	Not provided at time of registration
Publication and dissemination plan	Not provided at time of registration
IPD sharing plan

Study outputs

Output type	Details	Date created	Date added	Peer reviewed?	Patient-facing?
Results article	results	01/02/2007		Yes	No